Brief: Oragenics Inc Says Effective Dec 15, Kimberly Murphy, Co's President, CEO, Was Appointed Co's Interim Chief Financial Officer, Secretary, Treasurer
16/12/2022 21:55
Dec 16 (Reuters) - Oragenics Inc OGEN.A :
* ORAGENICS INC - EFFECTIVE DEC 15, KIMBERLY MURPHY, CO'S
PRESIDENT AND CEO, WAS APPOINTED CO'S INTERIM CHIEF FINANCIAL
OFFICER, SECRETARY AND TREASURER
Further company coverage: OGEN.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing